Biodesix Net Receivables from 2010 to 2025

BDSX Stock  USD 0.80  0.03  3.61%   
Biodesix Net Receivables yearly trend continues to be fairly stable with very little volatility. Net Receivables will likely drop to about 7.5 M in 2025. During the period from 2010 to 2025, Biodesix Net Receivables regression line of annual values had r-squared of  0.43 and arithmetic mean of  4,380,617. View All Fundamentals
 
Net Receivables  
First Reported
2019-09-30
Previous Quarter
M
Current Value
8.6 M
Quarterly Volatility
3.9 M
 
Covid
Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.9 M, as well as many indicators such as Price To Sales Ratio of 2.64, Dividend Yield of 0.0 or PTB Ratio of 7.36. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Latest Biodesix's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Biodesix over the last few years. It is Biodesix's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodesix's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Biodesix Net Receivables Regression Statistics

Arithmetic Mean4,380,617
Geometric Mean3,330,984
Coefficient Of Variation86.44
Mean Deviation2,890,271
Median1,892,000
Standard Deviation3,786,744
Sample Variance14.3T
Range13.4M
R-Value0.65
Mean Square Error8.8T
R-Squared0.43
Significance0.01
Slope518,571
Total Sum of Squares215.1T

Biodesix Net Receivables History

20257.5 M
20248.6 M
20237.7 M
20225.1 M
20213.7 M
202015.3 M
20195.3 M

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables8.6 M7.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.